Repligen | RGEN - النقدية وما يعادلها





النقدية وما يعادلها تغيير تاريخ
Agilent USD 1.76B 31M 2025-12
Align Technology USD 1.09B 90.32M 2025-12
Bio Techne USD 172.88M 27.92M 2025-12
BioMarin Pharmaceutical USD 2.22B 910.76M 2026-03
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Bruker USD 293.1M 201.1M 2025-09
Charles River Laboratories USD 213.77M 6.67M 2025-12
Danaher USD 5.7B 1.09B 2026-03
Dentsply International USD 190M 136M 2026-03
General Electric Aerospace USD 10.98B 1.41B 2026-03
Henry Schein USD 156M 20M 2025-12
Illumina USD 1.42B 368M 2025-12
IQVIA Holdings USD 1.95B 33M 2026-03
Mettler Toledo International USD 69.06M 7.24M 2025-09
Myriad Genetics USD 149.6M 4.2M 2025-12
OraSure Technologies USD 199.28M 17.2M 2025-12
Pacific Biosciences Of California USD 279.51M 223.04M 2025-12
Pfizer USD 1.7B 561M 2026-03
Repligen USD 566.02M 182.73M 2025-12
Revvity USD 919.86M 11.53M 2025-12
Standard Biotools USD 118.21M 11.2M 2025-12
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Waters USD 587.83M 128.71M 2025-12
West Pharmaceutical Services USD 521.4M 269.9M 2026-03